Condition
Corneal Wavefront Aberration
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Not Yet Recruiting2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07518316Not ApplicableNot Yet RecruitingPrimary
Factors Influencing Subjective Visual Quality in Human Eyes
NCT06425432Not Yet RecruitingPrimary
Higher Order Aberration and Relationship With Soft Contact Lens Modulus
NCT05882383CompletedPrimary
Changes of Optical Quality During the Peak of the Covid-19 Pandemic
NCT01663597Completed
Optical Biometry and Spherical Aberration in Ametropic and Emmetropic Eyes
Showing all 4 trials